Zantac
3 stories tracked · latest
847
Case tracking for the Zantac matter, current through August 11, 2026, plus any additional news coverage found automatically below. Allegations may be disputed; a listing does not establish liability or individual eligibility.
Recent coverage
Del. Judge Ends 80K Pre-2026 Zantac Cases - Law360
A Delaware judge has ended roughly 80,000 Zantac-related cases that were pending before 2026.
95 people with cancer sue CT's Boehringer Ingelheim over recalled drug Zantac - News-Times
Ninety-five cancer patients have sued Boehringer Ingelheim in Connecticut over the recalled heartburn medication Zantac.
11th Circuit open to reviving class action over heartburn drug linked to cancer - Courthouse News
The Eleventh Circuit is considering reinstating a proposed class action alleging that Zantac, a heartburn medication, was associated with cancer.
Curated matter facts are cited to public reporting and official sources and are not GPT-generated. Coverage above aggregates public news reporting using the GDELT news database and Google News, updated automatically without human review. It is general information, not legal advice, and does not indicate CaseValuation.com represents or is affiliated with any party, law firm, or plaintiff named above. CaseValuation.com is not a law firm. If you believe you're affected by one of these matters, consult a licensed attorney.